Philips and American Heart Association continue to advance cardiac
resuscitation with sixth annual fellowship award
ANDOVER, Mass., Nov. 5, 2012
ANDOVER, Mass., Nov. 5, 2012 /PRNewswire/ --Royal Philips Electronics (NYSE:
PHG, AEX: PHIA) today announced Nidia Quillinan, Ph.D., a post-doctoral fellow
at The Colorado Clinical and Translational Sciences Institute at the
University of Colorado, Denver, as the recipient of the sixth annual American
Heart Association (AHA)-Philips Resuscitation Fellowship Award.
The Fellowship Award provides a $100,000 grant, funded by Philips over two
years, and is presented annually to a researcher in the early stages of his or
her career to pursue basic and clinical research related to cardiac
resuscitation. The AHA selected Dr. Quillinan based on the merits of her
research proposal. Philips chose to support the award due to its applicability
to the field of resuscitation.
This year's grant will allow Dr. Quillinan to pursue research on global
transient ischemia caused by a heart attack. Dr. Quillinan will examine how
the condition affects Purkinje cells, which are the brain cells responsible
for motor coordination and learning, and synaptic plasticity, or the way the
synapses between cells change. The correlation between resuscitation and
Purkinje cells is a recent discovery and the opportunities and consequences of
this relationship remain unknown.
"Philips has a legacy of cardiac resuscitation innovations and accomplishments
that spans more than 50 years," said Derek Smith, senior vice president and
general manager, Therapeutic Care, Philips Healthcare. "The AHA fellowship
award allows the research community to share in our dedication to saving lives
by advancing knowledge of cardiac resuscitation. We are confident Dr.
Quillinan's research will uncover new evidence that will benefit the medical
and patient community."
The Fellowship Award was presented to Dr. Quillinan on November 3 at the
Resuscitation Science Symposium (ReSS) meeting in Los Angeles. This annual
event is held in conjunction with the AHA's Scientific Sessions.
Philips is a global leader in emergency care and cardiac resuscitation
solutions. In addition to being the worldwide leader for automated external
defibrillators (AEDs), Philips also offers advanced life support (ALS)
monitors, cardiographs, cardiology informatics, cardiac imaging systems and
temperature modulation therapy to help give patients the best cardiac care
possible. Philips' innovative solutions support patients through every step of
the cardiology care continuum, helping to prevent information delays and
shorten critical care times.
To learn more about Philips' resuscitation solutions visit
About Royal Philips Electronics
Royal Philips Electronics (NYSE: PHG, AEX: PHIA) is a diversified health and
well-being company, focused on improving people's lives through meaningful
innovation in the areas of Healthcare, Consumer Lifestyle and Lighting.
Headquartered in the Netherlands, Philips posted 2011 sales of EUR 22.6
billion and employs approximately 121,000 employees with sales and services in
more than 100 countries. The company is a leader in cardiac care, acute care
and home healthcare, energy efficient lighting solutions and new lighting
applications, as well as male shaving and grooming, home and portable
entertainment and oral healthcare. News from Philips is located at
SOURCE Royal Philips Electronics
Contact: Rachel Bloom-Baglin, +1-978-659-3748, Rachel.Bloom-Baglin@philips.com
Press spacebar to pause and continue. Press esc to stop.